Emagine Solutions Technology's VistaScan portable ultrasound enables doctors to enhance patient care. Clinicians can diagnose in moments, saving time and lives at a fraction of the cost of a cart ultrasound machine

Emagine Solutions Technology's VistaScan portable ultrasound enables doctors to enhance patient care. Clinicians can diagnose in moments, saving time and lives at a fraction of the cost of a cart ultrasound machine. Photo credit: Tech Parks Arizona


February 27, 2020 — Emagine Solutions Technology, an award-winning medical software device company located in Tucson, announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market its VistaScan mobile ultrasound platform. 

The VistaScan platform transforms a clinician's cell phone or tablet into a portable ultrasound solution. The system consists of compatible FDA cleared ultrasound probes that interface with the VistaScan software application. VistaScan's proprietary patent-pending Dynamic Precise Point Measuring System enables a healthcare provider to maximize the accuracy of a mobile device's touchscreen to make highly precise, to-the-pixel measurements on the ultrasound image, thereby increasing diagnostic performance and speed.  

"The velocity and complexity of modern medicine is becoming overwhelming, and putting the power of ultrasound into the pockets of clinicians so they can use it for real time diagnosis right at the bedside is liberating and transformative," commented Dr. Berndt Schmit, Section Chief of Emergency Radiology at Banner University Medical Center at the University of Arizona and President of Humanitarian Radiology Development Corps.

Emagine Solutions Technology has already won a number of accolades prior to its launch of VistaScan, including grant funding from National Science Foundation and Roddenberry Foundation, the Flinn Foundation Bioscience Entrepreneurship award, National AURP Award, and was a Governor's Celebration of Innovation Finalist this year. The company is also a Pipeline Angels investment portfolio company. 

"Receiving FDA clearance is excellent validation of our technology and demonstrates the role handheld ultrasound will play in enhancing patient care," commented Courtney Williams, co-founder and CEO of Emagine Solutions Technology.

Emagine Solutions Technology is a certified Women's Business Enterprise by the Women's Business Enterprise Council and was founded to expand access to diagnostic ultrasound technology, particularly in the area of women's health. 

For more information: www.vistascan.co


Related Content

News | Women's Health

Sept. 15, 2025 — GE HealthCare has launched the Voluson Performance series, the latest addition to its women’s health ...

Time September 15, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

Sept. 10, 2025 —GE HealthCare announced it has entered into an agreement to acquire icometrix, a company focused on ...

Time September 10, 2025
arrow
News | Lung Imaging

Sept. 4, 2025 — Sentec recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Time September 08, 2025
arrow
News | Computed Tomography (CT)

Sept. 4, 2025 — University Hospitals health system in Cleveland recently became the first healthcare institution in the ...

Time September 05, 2025
arrow
News | Computed Tomography (CT)

Sept. 4, 2025 — 4DMedical, a global medical technology company, has announced U.S. Food and Drug Administration (FDA) ...

Time September 04, 2025
arrow
News | Cardiac Imaging

Aug. 29, 2025 — GE HealthCare has launched Vivid Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ...

Time August 29, 2025
arrow
News | Computed Tomography (CT)

Aug. 26, 2025— Esaote North America, Inc., a provider of dedicated MRI, Ultrasound, and Healthcare IT solutions, has ...

Time August 27, 2025
arrow
News | Radiopharmaceuticals and Tracers

Aug. 21, 2025 — On Aug. 21, 2025, Nusano, a physics company transforming the production of radioisotopes, cut the ribbon ...

Time August 26, 2025
arrow
News | Computed Tomography (CT)

Aug. 12, 2025 — MARS Bioimaging has appointed of Dr. Ojas Mahapatra as Group Chief Executive Officer. Mahapatra is an ...

Time August 18, 2025
arrow
News | Point-of-Care Ultrasound (POCUS)

Aug. 12, 2025 —Sonic Incytes Medical Corp, has announced that the U.S. Food and Drug Administration (FDA) has granted ...

Time August 15, 2025
arrow
Subscribe Now